130 related articles for article (PubMed ID: 22882327)
1. Late-onset myasthenia not on the increase: a nationwide register study in Denmark, 1996-2009.
Pedersen EG; Hallas J; Hansen K; Jensen PE; Gaist D
Eur J Neurol; 2013 Feb; 20(2):309-14. PubMed ID: 22882327
[TBL] [Abstract][Full Text] [Related]
2. Identifying patients with myasthenia for epidemiological research by linkage of automated registers.
Pedersen EG; Hallas J; Hansen K; Jensen PE; Gaist D
Neuroepidemiology; 2011; 37(2):120-8. PubMed ID: 21986220
[TBL] [Abstract][Full Text] [Related]
3. Oral Immunosuppressive Treatment of Myasthenia Gravis in Denmark: A Nationwide Drug Utilization Study, 1996-2013.
Pedersen EG; Hallas J; Pottegård A; Hald SM; Jensen PEH; Gaist D
Basic Clin Pharmacol Toxicol; 2018 Oct; 123(4):486-493. PubMed ID: 29732733
[TBL] [Abstract][Full Text] [Related]
4. Mortality in myasthenia gravis: A nationwide population-based follow-up study in Denmark.
Hansen JS; Danielsen DH; Somnier FE; Frøslev T; Jakobsen J; Johnsen SP; Andersen H
Muscle Nerve; 2016 Jan; 53(1):73-7. PubMed ID: 25914186
[TBL] [Abstract][Full Text] [Related]
5. Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa.
Mombaur B; Lesosky MR; Liebenberg L; Vreede H; Heckmann JM
Muscle Nerve; 2015 Apr; 51(4):533-7. PubMed ID: 25060190
[TBL] [Abstract][Full Text] [Related]
6. A national epidemiological study of Myasthenia Gravis in Australia.
Gattellari M; Goumas C; Worthington JM
Eur J Neurol; 2012 Nov; 19(11):1413-20. PubMed ID: 22469211
[TBL] [Abstract][Full Text] [Related]
7. Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.
Somnier FE
Neurology; 2005 Sep; 65(6):928-30. PubMed ID: 16186537
[TBL] [Abstract][Full Text] [Related]
8. Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989.
Christensen PB; Jensen TS; Tsiropoulos I; Sørensen T; Kjaer M; Højer-Pedersen E; Rasmussen MJ; Lehfeldt E; de Fine Olivarius B
Neurology; 1993 Sep; 43(9):1779-83. PubMed ID: 8414031
[TBL] [Abstract][Full Text] [Related]
9. Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries.
Andersen JB; Heldal AT; Engeland A; Gilhus NE
Acta Neurol Scand Suppl; 2014; (198):26-31. PubMed ID: 24588503
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological study of adult-onset myasthenia gravis in the area of Belgrade (Serbia) in the period 1979-2008.
Lavrnic D; Basta I; Rakocevic-Stojanovic V; Stevic Z; Peric S; Nikolic A; Marjanovic I; Pekmezovic T
Neuroepidemiology; 2013; 40(3):190-4. PubMed ID: 23363926
[TBL] [Abstract][Full Text] [Related]
11. [The clinical characteristics of early-onset versus late-onset types of myasthenia gravis].
Wang W; Chen YP; Wei DN
Zhonghua Nei Ke Za Zhi; 2011 Jun; 50(6):496-8. PubMed ID: 21781535
[TBL] [Abstract][Full Text] [Related]
12. Incidence of seropositive myasthenia gravis in Cape Town and South Africa.
Bateman KJ; Schinkel M; Little F; Liebenberg L; Vincent A; Heckmann JM
S Afr Med J; 2007 Oct; 97(10):959-62. PubMed ID: 18000579
[TBL] [Abstract][Full Text] [Related]
13. Clinical and epidemiological features of myasthenia gravis in Chilean population.
Cea G; Martinez D; Salinas R; Vidal C; Hoffmeister L; Stuardo A
Acta Neurol Scand; 2018 Oct; 138(4):338-343. PubMed ID: 29845611
[TBL] [Abstract][Full Text] [Related]
14. The increasing incidence of infective endocarditis in Denmark, 1994-2011.
Erichsen P; Gislason GH; Bruun NE
Eur J Intern Med; 2016 Nov; 35():95-99. PubMed ID: 27339641
[TBL] [Abstract][Full Text] [Related]
15. A nationwide epidemiological study of myasthenia gravis in Latvia.
Zieda A; Ravina K; Glazere I; Pelcere L; Naudina MS; Liepina L; Kamsa I; Kurjane N; Woodhall M; Jacobson L; Leite MI; Tandon K; Kenina V
Eur J Neurol; 2018 Mar; 25(3):519-526. PubMed ID: 29194859
[TBL] [Abstract][Full Text] [Related]
16. [Clinical feature of late-onset myasthenia gravis].
Minami N
Nihon Rinsho; 2015 Sep; 73 Suppl 7():495-500. PubMed ID: 26480748
[No Abstract] [Full Text] [Related]
17. Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey.
Somnier FE; Keiding N; Paulson OB
Arch Neurol; 1991 Jul; 48(7):733-9. PubMed ID: 1859301
[TBL] [Abstract][Full Text] [Related]
18. [Late onset forms of myasthenia gravis. Comparison with early-onset myasthenia gravis].
Barbaud A; Carlander B; Pagès M
Rev Neurol (Paris); 2006 Oct; 162(10):990-6. PubMed ID: 17028567
[TBL] [Abstract][Full Text] [Related]
19. Myasthenia gravis in the county of Viborg, Denmark.
Sørensen TT; Holm EB
Eur Neurol; 1989; 29(3):177-9. PubMed ID: 2731568
[TBL] [Abstract][Full Text] [Related]
20. Myasthenia gravis requiring pyridostigmine treatment in a national population cohort.
Andersen JB; Engeland A; Owe JF; Gilhus NE
Eur J Neurol; 2010 Dec; 17(12):1445-50. PubMed ID: 20491896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
